All Posts Tagged Tag: ‘Eli Lilly’

Diabetes Treatment Drug Shows Encouraging Results in Trials

At the 48th annual meeting of the European Association for the Study of Diabetes (EASD) this week in Berlin, Boehringer Ingelheim Pharmaceuticals, and Eli Lilly announced data from three analyses for linagliptin, a new type 2 diabetes treatment. The studies found that linagliptin lowered hemoglobin A1C in elderly patients with type 2 diabetes and adults with type 2 diabetes and …

Read More